Clinical trial
European Infant Neuroblastoma Study - Unresectable Tumors (MYCN Not Amplified)
NCT00025597 is registered in ClinicalTrials.gov with European Infant Neuroblastoma Study Group - 1999 as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- European Infant Neuroblastoma Study - Unresectable Tumors (MYCN Not Amplified)
- Lead sponsor
- European Infant Neuroblastoma Study Group - 1999
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 1999
- Completion date
- February 28, 2011
- Enrollment
- Not reported
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.